MediFind
Condition

Renal Oncocytoma

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 165
  • Start Date: September 20, 2020
Fluciclovine (FACBC) PET/CT Site-Directed Therapy of Oligometastatic Prostate Cancer (Flu-BLAST-PC)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: August 14, 2020
A Phase I/II Study of Durvalumab (Medi 4736) and Stereotactic Ablative Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 30
  • Start Date: August 11, 2020
A Phase Ib Trial of Preoperative Short-Course Chemoradiotherapy Followed by Chemotherapy for Resectable Gastric Adenocarcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 135
  • Start Date: August 10, 2020
Phase II Clinical Trial of Green Tea Catechins in Men on Active Surveillance (AS)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 175
  • Start Date: July 8, 2020
PAXG Out in the Country
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 68
  • Start Date: July 1, 2020
Non-Operative Management and Early Response Assessment in Rectal Cancer
Clinical Trial
Radiation
  • Status: Recruiting
  • Study Type: Radiation
  • Participants: 24
  • Start Date: July 1, 2020
Phase I Study of NBTXR3 Activated by Radiotherapy for Locally Advanced or Borderline Resectable Pancreatic Ductal Adenocarcinoma
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 32
  • Start Date: July 1, 2020
A Phase I Clinical Trial of Regorafenib, Nivolumab, and Ipilimumab in Advanced Chemotherapy Resistant Metastatic MSS Colorectal Cancer